Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer

Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer

(2012) Elisabetta Munzone et al.   BREAST CANCER RESEARCH AND TREATMENT

Prognostic Value of Breast Cancer Subtypes, Ki-67 Proliferation Index, Age, and Pathologic Tumor Characteristics on Breast Cancer Survival in Caucasian Women

(2012) N. Lynn Ferguson et al.   Breast Journal

Condensed chromatin staining of CKAP2 as surrogate marker for mitotic figures

(2011) Han-Seong Kim et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

(2011) M. Dowsett et al.   JNCI-Journal of the National Cancer Institute

Breast Cancer Classification According to Immunohistochemistry Markers: Subtypes and Association With Clinicopathologic Variables in a Peruvian Hospital Database

(2010) Carlos S. Vallejos et al.   Clinical Breast Cancer

Ki67 in breast cancer: prognostic and predictive potential

(2010) Rinat Yerushalmi et al.   LANCET ONCOLOGY

Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer

(2010) REIKI NISHIMURA et al.   Experimental and Therapeutic Medicine

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

(2009) Judith Hugh et al.   JOURNAL OF CLINICAL ONCOLOGY

Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer

(2009) Frédérique Penault-Llorca et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

(2009) Reiki Nishimura et al.   Breast Cancer

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

(2008) Jan P. A. Baak et al.   BREAST CANCER RESEARCH AND TREATMENT

Transient phosphorylation of tumor associated microtubule associated protein (TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during early phases of mitosis

(2008) Kyung Uk Hong et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

(2008) Cornelia Liedtke et al.   JOURNAL OF CLINICAL ONCOLOGY